CELL THERAPEUTICS INC's ticker is and the CUSIP is 150934953. A total of 2 filers reported holding CELL THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $94,000 | -93.9% | 33,400 | -92.6% | 0.00% | -96.2% |
| Q1 2014 | $1,530,000 | +393.5% | 450,000 | +178.8% | 0.03% | +420.0% |
| Q4 2013 | $310,000 | +69.4% | 161,400 | +44.5% | 0.01% | +25.0% |
| Q3 2013 | $183,000 | +3560.0% | 111,700 | +2497.7% | 0.00% | – |
| Q2 2013 | $5,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 161,400 | $310,000 | 0.01% |
| Citadel Advisors | 25,500 | $49,000 | 0.00% |